Chase AIPricingFAQs
Display currency
Loading news…

Corestem Chemon

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Seongnam, Kyonggi-do, South Korea Founded 2003 1-10 employees For Profit

CorestemChemon is a cell biotechnology company that develops stem cell therapeutics for neurodegenerative disorders and autoimmune diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Ticker
166480
KOSDAQ - Korean Securities Dealers Automated Quotations

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
166480
Exchange
KOSDAQ - Korean Securities Dealers Automated Quotations
IPO date
Jul 1, 2015

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
17

Company Info

Founded
2003
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
HQ
Seongnam, Kyonggi-do, South Korea
Region
Asia-Pacific (APAC)
Exit date
Jul 1, 2015

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
0
Trend (30d)
-0.2
Trend (90d)
0.4
1
professional contacts at Corestem Chemon
Contact execs at Corestem Chemon

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Corestem Chemon

Loading news…

FAQs about Corestem Chemon

People who checked this page also checked these

Browse the full Acquirezy directory.
Corestem Chemon - Company Profile, Full Acquisitions List, Funding and Investments